On November 7, 2025, GSK plc bought back 170,000 of its ordinary shares at an average price of 1,772.64p as part of its buyback program, increasing its treasury shares to 255,623,844. This purchase is part of an ongoing strategy that has seen a total of 8,159,000 shares repurchased since September 30, 2025.